257 related articles for article (PubMed ID: 23644699)
1. Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.
Li X; Qu L; Zhong Y; Zhao Y; Chen H; Daru L
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1433-47. PubMed ID: 23644699
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer.
Liu D; Duan W; Guo H; Xu X; Bai Y
Int J Colorectal Dis; 2011 Sep; 26(9):1099-105. PubMed ID: 21538057
[TBL] [Abstract][Full Text] [Related]
3. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.
Liu D; Guo H; Li Y; Xu X; Yang K; Bai Y
PLoS One; 2012; 7(2):e31251. PubMed ID: 22348060
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk.
Yang TF; Guo L; Wang Q
Asian Pac J Cancer Prev; 2014; 15(3):1263-7. PubMed ID: 24606450
[TBL] [Abstract][Full Text] [Related]
5. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of matrix metalloproteinases affect the susceptibility of esophageal cancer: Evidence from 20412 subjects, systematic review and updated meta-analysis.
Chen H; Xu X; Hua C; Zhang H; Jian J; Ge T; Xie J; Yu Z
Medicine (Baltimore); 2021 Sep; 100(38):e27229. PubMed ID: 34559117
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L
Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.
Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H
PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
[TBL] [Abstract][Full Text] [Related]
10. Association between MMP-9 -1562 C/T polymorphism and susceptibility to digestive cancers: A meta-analysis.
Hu C; Weng F; Li L; Dai W; Yan J; Peng L; Zhou R
Gene; 2018 Oct; 673():88-94. PubMed ID: 29890308
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
[TBL] [Abstract][Full Text] [Related]
12. Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.
Ke P; Wu ZD; Wen HS; Ying MX; Long HC; Qing LG
Asian Pac J Cancer Prev; 2013; 14(4):2269-72. PubMed ID: 23725125
[TBL] [Abstract][Full Text] [Related]
13. Association between matrix metalloproteinases polymorphisms and ovarian cancer risk: A meta-analysis and systematic review.
Zhu XM; Sun WF
PLoS One; 2017; 12(9):e0185456. PubMed ID: 28957437
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
Liu C; Jiang Z; Deng QX; Zhao YN
Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
[TBL] [Abstract][Full Text] [Related]
15. Association of MMP2 and MMP9 gene polymorphisms with the recurrent spontaneous abortion: A meta-analysis.
Yan Y; Fang L; Li Y; Yu Y; Li Y; Cheng JC; Sun YP
Gene; 2021 Jan; 767():145173. PubMed ID: 33007375
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma.
Lièvre A; Milet J; Carayol J; Le Corre D; Milan C; Pariente A; Nalet B; Lafon J; Faivre J; Bonithon-Kopp C; Olschwang S; Bonaiti-Pellié C; Laurent-Puig P;
BMC Cancer; 2006 Nov; 6():270. PubMed ID: 17125518
[TBL] [Abstract][Full Text] [Related]
17. Association Between Matrix Metalloproteinase-1, 2, 3 Polymorphisms and Oral Cancer Risk: A Meta-Analysis.
Li Y; Wang Y; Sun H; Zhang Y; Li H; Cong X; Yin W; Song W
Genet Test Mol Biomarkers; 2018 Aug; 22(8):456-464. PubMed ID: 30117779
[TBL] [Abstract][Full Text] [Related]
18. Current evidence on the relationships among five polymorphisms in the matrix metalloproteinases genes and prostate cancer risk.
Gui J; Zhou H; Li S; Chen A; Liu Q; Zhu L; Mi Y
Sci Rep; 2024 May; 14(1):11355. PubMed ID: 38762659
[TBL] [Abstract][Full Text] [Related]
19. MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis.
Tao L; Li Z; Lin L; Lei Y; Hongyuan Y; Hongwei J; Yang L; Chuize K
Genet Test Mol Biomarkers; 2015 Oct; 19(10):548-55. PubMed ID: 26301605
[TBL] [Abstract][Full Text] [Related]
20. Associations between various possible promoter polymorphisms of MMPs genes and endometriosis risk: a meta-analysis.
Yang H; Liu J; Fan Y; Guo Q; Ge L; Yu N; Zheng X; Dou Y; Zheng S
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():174-88. PubMed ID: 27620811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
